NAD Recommends Serta Modify, Discontinue Certain Comparative Advertising Claims for ‘IComfort,’ Following Tempur-Pedic Challenge

New York, NY – Jan. 7, 2013 – The National Advertising Division has recommended that Serta, Inc., modify or discontinue certain comparative performance claims made for the company’s iComfort Sleep System, including claims that Serta’s product offers superior cooling benefits over competitor Tempur-Pedic Management, Inc.

NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.

Comparative performance claims made by Serta in Internet advertising and product brochures were challenged by Tempur-Pedic, including cooling claims (“Our cool action material sleeps cooler than ordinary memory foam”), air-flow claims (“Up to 12x more breathable”) and claims that compare the support, pressure relief and therapeutic benefits of the competing products.

NAD noted in its decision that while the case offered “ much in the way of complex technological advances in memory foam mattresses and how various aspects of a mattresses’ components may or may not impact the sleeping experience of consumers, the ultimate question is one that NAD handles every day: whether the advertiser’s claims convey a truthful, accurate and non-misleading message about the performance capabilities of the products it sells and its superior performance claims in comparison to the challenger’s competing products.”

NAD was mindful of Serta’s position that its testing substantiates comparative superiority claims that its products’ materials perform better than Tempur materials with respect to cooling, heat conductivity, air flow, etc., and its contention that its advertising claims speak directly in terms of the materials or components used in constructing the parties’ respective mattresses.

However, NAD concluded that the challenged claims could reasonably be interpreted by consumers as a direct comparison of the parties’ respective memory foam mattresses – not simply the products’ individual components or materials.

Although portions of the challenged advertisements speak in terms of Serta’s “materials” (i.e., gel beads, open cell structure, microsupport gel, gel memory foam, etc.), NAD determined that, “in the end, Serta is promoting complete, intact, iComfort Sleep System memory foam mattresses, not individual layers or components. Moreover, these claims are framed in the comparative context, asserting the superior quality and performance of its products as compared to its competitors.

Overall, NAD found studies submitted by Serta in support of its claims to be problematic, relying in part on tests of mattress samples, rather than complete mattresses, and failing to take into account the effect of bedding and nightclothes.

NAD recommended that the advertiser discontinue its inadequately supported comparative superiority “cooling” claims, as well as claims that independent testing proved that “iComfort is superior to Tempur-Pedic on all 3 factors essential to helping your customers sleep cooler” and related “testing” claims. NAD found that the evidence was insufficient to support Serta’s claim that its iComfort Sleep System offers “dramatically increase[d] airflow” and recommended that this claim be modified.

NAD recommended that the advertiser discontinue its comparative superiority claims regarding support and pressure relief, as well as its establishment claims that independent testing proves that iComfort provides “2x Support” and “uniquely designed to deliver lower average body pressure than other advanced comfort materials.”

Notwithstanding these findings, however, NAD noted that nothing in its decision precludes Serta from making more limited, stand-alone claims regarding product’s design.

Finally, NAD concluded that the Serta’s therapeutic claims, if modified to remove comparative references, were puffery.

Serta took issue with certain of NAD’s findings, but said in its advertiser’s statement that it would take NAD’s recommendations into account in future advertising.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary
Decision

National Advertising Division Recommends Lily of the Desert Nutraceuticals Discontinue “100% Pure Avocado Oil” Claim for Tropical Plantation Avocado Oil

New York, NY – April 15, 2024 – The National Advertising Division recommended that Lily of the Desert Nutraceuticals discontinue the claim “100% Pure Avocado Oil” for its Tropical Plantation Avocado Oil and avoid conveying the unsupported message that the product is 100% pure avocado...

Read the Decision Summary